miR-29a not only acted as a tumor suppressor by regulating its target genes Tcl1 and DNMT3 in chronic lymphocytic leukemia and lung cancer [14] but also up-regulated p53 levels and induced apoptosis in a p53-dependent manner [15]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.